26.76 USD
▼-0.76-2.76%
盘后 26.64 -0.45%
2026-09-15
市值
$4.75B
市盈率
12.48
EPS
2.21
股息率
—
52 周区间
19.69 – 30.96
成交量
1.11M
Beta
0.86
目标价
34.00
52W 低 19.6952W 高 30.96
价格走势
公司简介
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America. The company offers NUPLAZID (pimavanserin), a selective serotonin inverse agonist/antagonist for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis; and DAYBUE, a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 to treat the symptoms of Rett syndrome by reducing neuroinflammation and supporting sy...